Yıldız İbrahim, Aksu Ebubekir, Özmen Yıldız Pınar Özmen, Gürbak İsmail
Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey.
Department of Thoracic Surgery, Osmaniye State Hospital, Osmaniye, Turkey.
Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Jan 1;27(1):118-120. doi: 10.5606/tgkdc.dergisi.2019.15090. eCollection 2019 Jan.
New oral anticoagulants have emerged as an alternative for warfarin for thromboembolic prevention in patients with nonvalvular atrial fibrillation. Although new oral anticoagulants have better compliance and safety margin compared to warfarin, we must be cautious with their usage. In this article, we report a case of spontaneous hemothorax related to rivaroxaban treatment. According to our research, this is the first case of spontaneous hemothorax secondary to rivaroxaban treatment.
新型口服抗凝药已成为华法林的替代药物，用于非瓣膜性心房颤动患者的血栓栓塞预防。尽管新型口服抗凝药与华法林相比具有更好的依从性和安全边际，但我们在使用时仍须谨慎。在本文中，我们报告了一例与利伐沙班治疗相关的自发性血胸病例。根据我们的研究，这是首例继发于利伐沙班治疗的自发性血胸病例。
